GBMB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Inovio Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 11.94 EUR 7.76% Market Closed

Market Cap: €22.6m

I	Inovio Pharmaceuticals Inc F:GBMB	US
	Rekor Systems Inc NASDAQ:REKR	US
	East Money Information Co Ltd SZSE:300059	CN
B	Banco Santander SA DUS:BSD2	ES
	Carebook Technologies Inc F:PMM1	CA
	Sysco Corp NYSE:SYY	US
B	Bukit Sembawang Estates Ltd SWB:B1W1	SG
N	Nextera Energy Partners LP F:1N6	US
N	Nhoa SA OTC:ENGPF	FR
	Enphase Energy Inc NASDAQ:ENPH	US
V	VivoPower International PLC F:51J	US
	Nedap NV AEX:NEDAP	NL
	J B Hunt Transport Services Inc NASDAQ:JBHT	US
E	Erste Group Bank AG DUS:EBO	AT
P	Perenti Ltd XMUN:FWG	AU
S	Shanghai Electric Group Co Ltd XBER:USR	CN
	Savills PLC LSE:SVS	UK

Profitability Summary

Inovio Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-45 463%

Low Net Margin

Negative 3Y Average Net Margin

-44 925%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-44 203%

Negative ROE

-296%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-638%

ROIC is Increasing

-1 045% > -713%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.